MedPath

Intima Media Thickness Regression in Dyslipidemic Teenagers

Phase 3
Completed
Conditions
Obesity
Dyslipidemia
Interventions
Drug: sugar pill
Registration Number
NCT01768481
Lead Sponsor
Université de Montréal
Brief Summary

Randomized controlled trial of statin intervention in dyslipidemic obese teenagers. Primary outcome is intima media thickness before and after intervention.

Detailed Description

Obese teenagers with abnormal lipid profiles were randomized to either low dose statin or placebo and had their carotid intima media thickness compared before and after intervention.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
16
Inclusion Criteria
  • Obesity
  • Abnormal Triglyceride levels (>1.7mmol/L).
  • Abnormal HDL-C levels (1.0mmol/L)
Exclusion Criteria
  • Abnormal thyroid unfction (not treated)
  • Diabetes

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
StatinAtorvastatinAtorvastatin 10 mg every day for one year
Sugar pillsugar pillSame size, taste and size placebo tablet (manufactured by sponsor) given every day for one year.
Primary Outcome Measures
NameTimeMethod
carotid intima media thickness12 months

Carotid Intima media thickness measured at baseline and after 12 months in 2 arms (placebo and statin)

Secondary Outcome Measures
NameTimeMethod
weight12 months

weight, height and BMI recorded before and after intervention

Trial Locations

Locations (1)

Hôpital Maisonneuve-Rosemont

🇨🇦

Montréal, Quebec, Canada

© Copyright 2025. All Rights Reserved by MedPath